Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 17 papers were listed this time. Here's a couple in our areas of research interest:
Cheng TF, Wang JD, Uen WC. Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer. BMC Cancer. 2012 Jan 21;12(1):33. [Epub ahead of print] PubMed PMID: 22264299.
van Rosmalen J, de Kok I, van Ballegooijen M. Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing. BJOG. 2012 Jan 18. [Epub ahead of print] PubMed PMID: 22251259.
